ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005060:Europe; D005260:Female; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods*; D018570:Risk Assessment
D000970:Antineoplastic Agents